levetiracetam hetero europe 1000 mg filmdragerad tablett
hetero europe s.l. - levetiracetam - filmdragerad tablett - 1000 mg - levetiracetam 1000 mg aktiv substans - levetiracetam
levetiracetam hetero europe 250 mg filmdragerad tablett
hetero europe s.l. - levetiracetam - filmdragerad tablett - 250 mg - levetiracetam 250 mg aktiv substans - levetiracetam
levetiracetam hetero europe 500 mg filmdragerad tablett
hetero europe s.l. - levetiracetam - filmdragerad tablett - 500 mg - levetiracetam 500 mg aktiv substans - levetiracetam
levetiracetam hetero europe 750 mg filmdragerad tablett
hetero europe s.l. - levetiracetam - filmdragerad tablett - 750 mg - levetiracetam 750 mg aktiv substans; para-orange aluminiumlack hjälpämne - levetiracetam
rigmin 13,3 mg/24 timmar depotplåster
sandoz a/s - rivastigmin - depotplåster - 13,3 mg/24 timmar - rivastigmin 27 mg aktiv substans - rivastigmin
rigmin 4,6 mg/24 timmar depotplåster
sandoz a/s - rivastigmin - depotplåster - 4,6 mg/24 timmar - rivastigmin 9 mg aktiv substans - rivastigmin
rigmin 9,5 mg/24 timmar depotplåster
sandoz a/s - rivastigmin - depotplåster - 9,5 mg/24 timmar - rivastigmin 18 mg aktiv substans - rivastigmin
rivastigmin ebb 13,3 mg/24 timmar depotplåster
ebb medical ab - rivastigmin - depotplåster - 13,3 mg/24 timmar - rivastigmin 27 mg aktiv substans
solymbic
amgen europe b.v. - adalimumab - arthritis, psoriatic; spondylitis, ankylosing; crohn disease; colitis, ulcerative; hidradenitis suppurativa; psoriasis; arthritis, rheumatoid - immunsuppressiva - se avsnitt 4. 1 i sammanfattningen av produktegenskaper i produktinformationsdokumentet.
zavicefta
pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibakteriella medel för systemiskt bruk, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. hänsyn bör tas till officiella riktlinjer för lämplig användning av antibakteriella medel.